Brenda Mann is VP at EYEGATE PHARMACEUTICALS INC (EYEG). They have made 1 open-market trade across 1 company since 2019, most recently 2021-11-02.
CIK 0001668858
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EYEG | 15,136 | $523K |
Shares reported on the most recent Form 4, priced at the 2021-11-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EYEG | SELL | 2019-07-11 | 2019-07-15 | $0.24 | $9K | -9.9% | -15.5% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.